This is a limited company view. Sign up for a Free Trial to see everything.

Virobay develops small molecule, antiviral drug treatments for autoimmune diseases, neuropathic pain, liver diseases and cancer.

B2B
Biotechnology
Cleantech
Healthcare
Pharmaceuticals
Wind Power

Overview

Location

Bay Area

Founded

Employees

8

Stage

Series B

Total funding

$18M

Last funding

4 years ago

Acquisitions

0

Growth score

0

Mindshare score

0

Scoring

Deals

$8.0M Series B

Sutter Hill Ventures, Alta Partners

Jul 16, 2014

$10.0M Series B

Sutter Hill Ventures, Alta Partners

Jun 16, 2010

Employee Growth

Use Virobay's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Virobay's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Associate Director of Medicinal Chemistry
VP & Chief Medical Officer

Similar Companies

Arvinas

We are developing first-in-class protein degradation therapeutics to degrade & destroy disease-causing proteins via the body's own protein disposal system.
Series B|51 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes